Antibiotics Used for COVID-19 In-Patients from an Infectious Disease Ward
Background: although the prevalence of bacterial co-infections for COVID-19 patients is very low, most patients receive empirical antimicrobial therapy. Furthermore, broad spectrum antibiotics are preferred to narrow spectrum antibiotics. Methods: in order to estimate the excess of antibiotic prescr...
Main Authors: | Felicia Sturza, Ștefan-Decebal Guță, Gabriel-Adrian Popescu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/1/150 |
Similar Items
-
Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis
by: Maria Calderon, et al.
Published: (2023-01-01) -
Antibiotic Therapy in the Treatment of COVID-19 Pneumonia: Who and When?
by: Tat Ming Ng, et al.
Published: (2022-01-01) -
Antibiotics Prescribing in Intensive Care Settings during the COVID-19 Era: A Systematic Review
by: Lubna I. Abu-Rub, et al.
Published: (2021-08-01) -
Profile of Co-Infection Prevalence and Antibiotics Use among COVID-19 Patients
by: Rita Greco, et al.
Published: (2022-10-01) -
Antibiotics Use in COVID-19 Patients: A Systematic Literature Review
by: Guido Granata, et al.
Published: (2022-12-01)